查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1540827

2024-2032 年按产品类型、技术（比较基因组杂交、萤光原位杂交、免疫组织化学、核型分析等）、应用、最终用户和地区分類的分子细胞遗传学市场报告

Molecular Cytogenetics Market Report by Product Type, Technology (Comparative Genomic Hybridization, Fluorescence in SITU Hybridization, Immunohistochemistry, Karyotyping, and Others), Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

2023年全球分子细胞遗传学IMARC Group规模达27亿美元。

分子细胞遗传学是指透过脱氧核糖核酸 (DNA) 机制研究基因突变和疾病的生物医学研究。它研究染色体及其细胞核的结构和功能组织、基因组变异、表达、进化和异常，特别是在医学和癌症相关遗传学方面。 DNA 扩增、DNA 分离、基因筛选、虚拟核型分析和萤光原位杂交 (FISH) 等技术通常用于分子细胞遗传学，透过使用 DNA 探针来视觉化和标记基因组或其目标区域。这些技术对于各种恶性肿瘤和血液系统恶性肿瘤的诊断和治疗非常有益。

癌症和其他遗传性疾病盛行率的增加以及老年人口的增加是推动市场成长的关键因素之一。分子细胞遗传学主要用于开发疾病特征的预测模型和有效的治疗策略。此外，癌症治疗标靶疗法的广泛采用也促进了市场的成长。 FISH 和比较基因组杂交 (CGH) 也用于药物基因组生物标记研究，以分析癌症进展阶段并为患者提供个人化治疗。此外，各种技术进步，例如改进的消耗品、试剂、软体和套件的开发，也是其他成长诱导因素。这些进步有助于产生可重复、准确且可靠的临床病理测试结果。其他因素，包括医疗保健基础设施的显着改善，以及生物医学领域的广泛研发（R&D）活动，预计将进一步推动市场发展。

本报告回答的关键问题

  • 2023年全球分子细胞遗传学市场规模有多大？ 2024-2032年全球分子细胞遗传学市场的预期成长率是多少？
  • COVID-19 对全球分子细胞遗传学市场有何影响？
  • 推动全球分子细胞遗传学市场的关键因素是什么？
  • 根据产品类型，全球分子细胞遗传学市场的细分情况如何？
  • 基于该技术的全球分子细胞遗传学市场的细分情况如何？
  • 全球分子细胞遗传学市场基于应用的细分情况如何？
  • 基于最终用户的全球分子细胞遗传学市场的细分是什么？
  • 全球分子细胞遗传学市场的关键区域有哪些？
  • 全球分子细胞遗传学市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球分子细胞遗传学市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品类型

  • 仪器仪表
    • 市场趋势
    • 市场预测
  • 耗材
    • 市场趋势
    • 市场预测
  • 软体和服务
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依技术

  • 比较基因组杂交
    • 市场趋势
    • 市场预测
  • 萤光原位杂交 (FISH)
    • 市场趋势
    • 市场预测
  • 免疫组织化学
    • 市场趋势
    • 市场预测
  • 核型分析
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按应用

  • 遗传性疾病
    • 市场趋势
    • 市场预测
  • 肿瘤学
    • 市场趋势
    • 市场预测
  • 个人化医疗
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 临床和研究实验室
    • 市场趋势
    • 市场预测
  • 医院和病理实验室
    • 市场趋势
    • 市场预测
  • 製药和生物技术公司
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Applied Spectral Imaging Inc.
    • Biological Industries
    • Bio-RAD Laboratories Inc.
    • BioView Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Oxford Gene Technology
    • Perkinelmer Inc.
    • Quest Diagnostics Incorporated
Product Code: SR112024A2623

The global molecular cytogenetics market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.0 Billion by 2032, exhibiting a growth rate (CAGR) of 9.1% during 2024-2032.

Molecular cytogenetics refers to the biomedical research of deoxyribonucleic acid (DNA) mechanisms to investigate genetic mutations and disorders. It studies the structural and functional organization of the chromosomes and their nucleus, genomic variations, expression, evolution and abnormalities, especially in medicinal and cancer-related genetics. Techniques such as DNA amplification, DNA isolation, gene screens, virtual karyotyping and fluorescence in situ hybridization (FISH) are commonly used for molecular cytogenetics by using DNA probes to visualize and label the genome or its targeted regions. These techniques are highly beneficial in the diagnosis and treatment of various malignant tumors and hematological malignancies.

The increasing prevalence of cancer and other genetic disorders, along with the rising geriatric population, is one of the key factors driving the growth of the market. Molecular cytogenetics is primarily being used for developing predictive models of disease traits and effective treatment strategies. Furthermore, the widespread adoption of targeted therapies for cancer treatment is also augmenting the market growth. FISH and Comparative Genomic Hybridization (CGH) are also used for pharmacogenomic biomarker studies to analyze cancer progression stages and provide personalized treatment to the patient. Additionally, various technological advancements, such as the development of improved consumables, reagents, software and kits, are acting as other growth-inducing factors. These advancements aid in generating duplicatable, accurate and reliable clinical-pathological test results. Other factors, including significant improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biomedical sciences, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular cytogenetics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, technology, application and end user.

Breakup by Product Type:

Instruments

Consumables

Software and Services

Others

Breakup by Technology:

Comparative Genomic Hybridization

Fluorescence in SITU Hybridization (FISH)

Immunohistochemistry

Karyotyping

Others

Breakup by Application:

Genetic Disorders

Oncology

Personalized Medicine

Others

Breakup by End User:

Clinical and Research Laboratories

Hospitals and Pathology Laboratories

Pharmaceutical and Biotechnology Companies

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Applied Spectral Imaging Inc., Biological Industries, Bio-RAD Laboratories Inc., BioView Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., Oxford Gene Technology, Perkinelmer Inc. and Quest Diagnostics Incorporated.

Key Questions Answered in This Report

  • 1. What was the size of the global molecular cytogenetics market in 2023?
  • 2. What is the expected growth rate of the global molecular cytogenetics market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global molecular cytogenetics market?
  • 4. What are the key factors driving the global molecular cytogenetics market?
  • 5. What is the breakup of the global molecular cytogenetics market based on the product type?
  • 6. What is the breakup of the global molecular cytogenetics market based on the technology?
  • 7. What is the breakup of the global molecular cytogenetics market based on application?
  • 8. What is the breakup of the global molecular cytogenetics market based on the end user?
  • 9. What are the key regions in the global molecular cytogenetics market?
  • 10. Who are the key players/companies in the global molecular cytogenetics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Molecular Cytogenetics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Comparative Genomic Hybridization
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Fluorescence in SITU Hybridization (FISH)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunohistochemistry
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Karyotyping
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Genetic Disorders
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Personalized Medicine
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Clinical and Research Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and Pathology Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Agilent Technologies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Applied Spectral Imaging Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Biological Industries
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Bio-RAD Laboratories Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 BioView Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Danaher Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 F. Hoffmann-La Roche AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 SWOT Analysis
    • 15.3.9 Illumina Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Oxford Gene Technology
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Perkinelmer Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Quest Diagnostics Incorporated
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials

List of Figures

  • Figure 1: Global: Molecular Cytogenetics Market: Major Drivers and Challenges
  • Figure 2: Global: Molecular Cytogenetics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Molecular Cytogenetics Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Molecular Cytogenetics Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Molecular Cytogenetics Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Molecular Cytogenetics Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Molecular Cytogenetics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Molecular Cytogenetics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Molecular Cytogenetics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Molecular Cytogenetics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Molecular Cytogenetics (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Molecular Cytogenetics (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Molecular Cytogenetics (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Molecular Cytogenetics (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Molecular Cytogenetics (Other Product Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Molecular Cytogenetics (Other Product Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Molecular Cytogenetics (Comparative Genomic Hybridization) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Molecular Cytogenetics (Comparative Genomic Hybridization) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Molecular Cytogenetics (Fluorescence in SITU Hybridization - FISH) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Molecular Cytogenetics (Fluorescence in SITU Hybridization - FISH) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Molecular Cytogenetics (Immunohistochemistry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Molecular Cytogenetics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Molecular Cytogenetics (Karyotyping) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Molecular Cytogenetics (Karyotyping) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Molecular Cytogenetics (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Molecular Cytogenetics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Molecular Cytogenetics (Genetic Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Molecular Cytogenetics (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Molecular Cytogenetics (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Molecular Cytogenetics (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Molecular Cytogenetics (Personalized Medicine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Molecular Cytogenetics (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Molecular Cytogenetics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Molecular Cytogenetics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Molecular Cytogenetics (Clinical and Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Molecular Cytogenetics (Clinical and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Molecular Cytogenetics (Hospitals and Pathology Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Molecular Cytogenetics (Hospitals and Pathology Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Molecular Cytogenetics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Molecular Cytogenetics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Molecular Cytogenetics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Molecular Cytogenetics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: North America: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: North America: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: United States: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: United States: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Canada: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Canada: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Asia Pacific: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Asia Pacific: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: China: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: China: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Japan: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Japan: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: India: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: India: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: South Korea: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: South Korea: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Australia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Australia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Indonesia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Indonesia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Europe: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Europe: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Germany: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Germany: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: France: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: France: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: United Kingdom: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: United Kingdom: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Italy: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Italy: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Spain: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Spain: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Russia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Russia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Latin America: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Latin America: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Brazil: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Brazil: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Mexico: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Mexico: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Middle East and Africa: Molecular Cytogenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Middle East and Africa: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Global: Molecular Cytogenetics Industry: SWOT Analysis
  • Figure 92: Global: Molecular Cytogenetics Industry: Value Chain Analysis
  • Figure 93: Global: Molecular Cytogenetics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Molecular Cytogenetics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Molecular Cytogenetics Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Molecular Cytogenetics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Molecular Cytogenetics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Molecular Cytogenetics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Molecular Cytogenetics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Molecular Cytogenetics Market Structure
  • Table 8: Global: Molecular Cytogenetics Market: Key Players